Decreasing the ability of HCT116 cells to escape from therapy induced senescence by increasing the duration of doxorubicin treatment
Contacts: Maria Anatolievna Zamkova zamkovam@gmail.com Introduction. Due to the toxicity of high doses of chemotherapy, low concentrations used in cancer treatment leads to the development of senescence phenotype in tumor cells, characterized by a block in the cell cycle progression and the absence...
Saved in:
| Main Authors: | N. A. Persiyantseva, S. Yu. Vikhrova, M. S. Korotkova, D. B. Kazansky, V. V. Tatarsky, M. A. Zamkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knockout of the sulfide: quinone oxidoreductase SQR reduces growth of HCT116 tumor xenograft
by: Ting Lu, et al.
Published: (2025-06-01) -
Study of caspase-6 activity in aggressive HCT116 cells using methotrexate-encapsulated lactoferrin-conjugated solid lipid nanoparticles via in silico and in vitro approaches
by: Sankha Bhattacharya, et al.
Published: (2025-07-01) -
Anticarcinogenic effect of gold nanoparticles synthesized from Albizia lebbeck on HCT-116 colon cancer cell lines
by: Harikrishna Malaikolundhan, et al.
Published: (2020-01-01) -
Green synthesis of silver nanoparticles using Magnolia alba leaf extracts and evaluating their antimicrobial, anticancer, antioxidant, and photocatalytic properties
by: Shaveen De Mel, et al.
Published: (2025-07-01) -
Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
by: Wen Zhang, et al.
Published: (2021-11-01)